Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer
Crossref DOI link: https://doi.org/10.1038/bjc.2014.401
Published Online: 2014-08-12
Published Print: 2014-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Choughule, A
Sharma, R
Trivedi, V
Thavamani, A
Noronha, V
Joshi, A
Desai, S
Chandrani, P
Sundaram, P
Utture, S
Jambhekar, N
Gupta, S
Aich, J
Prabhash, K
Dutt, A
Text and Data Mining valid from 2014-08-12
Article History
First Online: 12 August 2014